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Abstract
Background: The NLRP (Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing)
family, also referred to as NALP family, is well known for its roles in apoptosis and inflammation. Several NLRPs have been
indicated as being involved in reproduction as well.
Methodology: We studied, using the unique human gametes and embryo materials, the expression of the NLRP family in
human gametes and preimplantation embryos at different developmental stages, and compared the expression levels
between normal and abnormal embryos using real-time PCR.
Principal Findings: Among 14 members of the NLRP family, twelve were detected in human oocytes and preimplantation
embryos, whereas seven were detected in spermatozoa. Eight NLRPs( NLRP4, 5, 8, 9, 11, 12, 13, and 14) showed a similar
expression pattern: their expression levels were high in oocytes and then decreased progressively in embryos, resulting in a
very low level in day 5 embryos. However, NLRP2 and NLRP7 showed a different expression pattern: their expression
decreased from oocytes to the lowest level by day 3, but increased again by day 5. The expression levels of NLRP5, 9, and 12
were lower in day 1 abnormal embryos but higher in day3 and day5 arrested embryos, when compared with normal
embryos at the same stages. NLRP7 was down-regulated in day 1 and day 5 abnormal embryos but over-expressed in day3
arrested embryos.
Conclusions: According to our results, different NLRPs possibly work in a stage-dependent manner during human
preimplantation development.
Citation: Zhang P, Dixon M, Zucchelli M, Hambiliki F, Levkov L, et al. (2008) Expression Analysis of the NLRP Gene Family Suggests a Role in Human
Preimplantation Development. PLoS ONE 3(7): e2755. doi:10.1371/journal.pone.0002755
Editor: Jean-Nicolas Volff, Ecole Normale Supe ´rieure de Lyon, France
Received April 3, 2008; Accepted June 27, 2008; Published July 23, 2008
Copyright:  2008 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by grants from the Swedish Research Council, Stockholm County and Karolinska University Hospital (ALF), Academy of
Finland and Sigrid Juse ´lius Foundation.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: juha.kere@biosci.ki.se
. These authors contributed equally to this work.
Introduction
The NLRP (Nucleotide-binding oligomerization domain, Leucine
rich Repeat and Pyrin domain containing) family of cytoplasmic
proteins comprises 14 members with similar structure. They are
located in two clusters on human chromosome 11p15 (NLRP6, 10
and 14) and 19q 13.4 (NLRP2, 4, 5, 7, 8, 9, 11, 12 and 13). Most of
the family members are widely expressed in various tissues and well
conserved from C. elegans, D. melanogaster, rat, and mouse to human
(Information recruited from Human Genome Browser Gateway:
http://genome.ucsc.edu/cgi-bin/hgGateway). It has been impli-
cated that NLRPs participate in apoptosis and inflammation by
activation of caspases [1,2], where NLRPs are more commonly
referred to as NALPs [1], PANs [3] or PYPAFs [4].
Several NLRPs have been found to be related to reproduction.
Down-regulation of NLRP expression is connected with oocyte
aging in mice [5]. NLRP5 (also known as Mater) null female mice
are sterile because their embryos arrest at the two-cell stage [6].
Another NLRP member in mice, NLRP iota, is also required for
normal preimplantation development. Injection of siRNA against
NLRP iota into fertilized eggs results in arrested development of
embryos between 1-cell and 8-cell stages [5]. A mutation in human
NLRP7 has been found to be associated with recurrent hydatidiform
moles, spontaneous abortions, stillbirths and intrauterine growth
retardation [7,8]. Additionally, over-expression of NLRP7 is related
to development of testicular seminomas in humans [9]. NLRP14
mutation was discovered in five of 157 men with azoospermaia or
severe oligozoospermia [10]. Transcripts of NLRP5, NLRP8a n d
NLRP9 [11], and the protein of NLRP5 [12], have been detected in
bovine oocytes and preimplantation embryos.
We reported earlier the expression of NLRP5 in human fully-
grown GV oocytes [13]. Here, we studied, using the unique
human gametes and embryo materials, the expression of all the 14
NLRP members in human gametes and preimplantation embryos
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2755at day 2 (D2), day3 (D3), day 5 (D5), and compared their
expression levels between normal and abnormal embryos.
According to our results, different NLRPs possibly work in a
stage-dependent manner during early human development.
Results
Selection of PSMB6 as an internal control gene
In order to compare gene expression levels across several
developmental stages, it is essential to relate the test gene to control
genes (‘‘housekeeping genes’’) that are stably expressed at the
different developmental stages. We started by studying the
expression of two commonly used internal control genes: beta-
actin and GAPDH in human oocytes and embryos, but found that
the expression levels of these two genes in human oocytes and
embryos were not stable enough to act as good internal controls.
The instability of beta-actin and GAPDH has also been observed
in both bovine and mouse oocytes and embryos [14,15]. Hence,
we then selected housekeeping/maintenance genes from the list
provided by Affymextrix. They have tested 11 different human
adult and fetal tissues and found 47 transcripts expressed at the
same level in all the tissues [16]. PSMB6 and EEF1A1 are listed
among these 47 genes. Our microarray data (Zhang et al.
unpublished) showed that both were expressed at similar levels in
human oocytes and embryos. We verified the results by testing the
expression of PSMB6 and EEF1A1 at five developmental stages in
oocytes (GV, MI, MII) and embryos (D2, D3, D5). Real-time PCR
showed the same pattern for PSMB6, but not for EEF1A1. The
average Ct value of PSMB6 in individual oocytes and embryos was
29.0760,79 (Mean6SD). PSMB6 was therefore chosen as a stable
internal control in real-time PCR when human oocytes and/or
embryos are used, especially when the tested genes have similar
expression levels as PSMB6.
Expression of NLRP family genes in normal development
from oocytes to day 5 embryos
We used Affymetrix arrays to monitor global gene expression
during five stages of early human development (Zhang et al.,
unpublished). The results suggested that almost all NLRP family
genes were expressed during development. In order to verify and
extend the findings, we performed quantitative RT-PCR assays for
each NLRP gene. The specificity of the PCR product was confirmed
by both dissociation curveandgelelectrophoresis.A single peak was
observed in all the dissociation curves and a single band was seen on
the gel at the correct product size for each gene (Fig. 1).
Among 14 members of the NLRP family, twelve were detected
in human oocytes and embryos, whereas seven were detected in
spermatozoa (Fig. 1). NLRP2, 4, 5, 7, 8, 9, 11, 12, 13, and 14 were
detected in GV, MI, MII oocytes and D2, D3, and D5 embryos.
NLRP1 was detected in GV, MI, MII oocytes and D2 embryos,
but not in later stages. NLRP3 was only detected in GV, MI
oocytes and spermatozoa. NLRP2, 4, 6, 7, 11, 12 and 14 were
detected in spermatozoa. NLPR 6 was not detected in oocytes and
embryos. NLRP10 was not detected in any gametes or embryos.
Among the ten NLRPs (2, 4, 5, 7, 8, 9, 11, 12, 13, 14) that were
detected in all the oocytes and embryos, microarrays showed two
different expression patterns (Fig 2A and B). Except for NLRP2
and NLRP7, the rest were highly expressed in oocytes and then
gradually decreased in embryos with a very low level in D5
embryos. The expression of NLRP2 and NLRP7 followed a similar
pattern up to D3, but then showed a sharp increase in D5. These
expression patterns were consistent with those revealed by real-
time PCR (Fig. 3A and B).
Expression of NLRPs in developmentally arrested
embryos
To figure out the possible roles of NLRPs in oocyte maturation,
fertilization and early embryonic development, we compared the
expression ofNLRPs betweennormaland abnormalembryos.Aswe
were unable to acquire normal day 1 (D1) embryos, we compared
D1 abnormal embryos with normal D2 embryos (see explanation in
discussion part). NLRP5a n dNLRP9 showed 5 times lower
expression levelsin unfertilized oocytes than innormal D2 embryos,
whileNLRP12and NLRP7showed3timesand2.5timeslowerlevels
respectively. In 1PN and 3PN embryos, the expression of NLRP9
Figure 1. Detection of of NLRPs in human gametes and embryos
by PCR. PCR products were about 70 bp in GV, MI, MII oocytes, day2
(D2), day 3(D3), day 5(D5) embryos and spermatozoa (S). M: marker.
NLRP1 was detected in GV, MI, MII oocytes and D2 embryos, but not in
later stages. NLRP2, 4, 7, 11, 12 and 14 were detected in all samples.
NLRP3 was only detected in GV, MI oocytes and spermatozoa. NLRP5, 8,
9, 13 were detected in all oocytes and embryos, but not in spermatozoa.
NLPR6 was only detected in spermatozoa and NLRP10 was not detected
in any gametes or embryos (figure not shown).
doi:10.1371/journal.pone.0002755.g001
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decrease of NLRP5, 12, and 7 was not significant (Fig. 4).
We also compared the expression levels of NLRP5, 9, 12 and 7
between development-arrested embryos and normal ones at D3
and D5. All four genes had a higher expression level in
development-arrested embryos at D3 than in normal ones. Their
expression levels increased 1.5, 2.0, 3.4 and 1.3 times respectively
(Fig. 5A). In D5 development-arrested embryos, NLRP5, NLRP9
and NLRP12 had a higher expression level than in normal D5
embryos. The fold change was 32, 29 and 17 respectively.
Oppositely, the expression of NLRP7 was 50 times lower in
development-arrested D5 embryos (Fig. 5B).
Phylogenetic analysis of NLRP genes in mammals
To further predict the structure and function of the NLRP
family, we did phylogenetic analysis of the NLRP family using
protein sequences from both mice and humans. The results (Fig. 6)
showed a high homology of NLRP members between mouse and
human, except for NLRP8. The cluster of the NLRP members by
the phylogenetic analysis fitted well with their expression patterns
in human oocytes and embryos, such as NLRP2 and NLRP7.
Another cluster was NLRP1, 6, 10, 3. All 4 of these genes were
expressed at relatively low levels in oocytes and embryos. Notably,
the gene closest to NLRP5 was NLRP13, suggesting that NLRP13
might have a similar function to NLPR5. It would be interesting to
further test the function of NLRP13, both in mice and humans.
Discussion
For the first time, we report here a comprehensive expression
picture of the NLRP family in human gametes and preimplantation
embryos. Their expression patterns were confirmed by both
microarray and real-time PCR. We found downregulation of NLRP5,
9, 12 and 7 in D1 abnormal embryos and upregulation of NLRP5, 9,
and 12 in development-arrested embryos both at D3 and D5. NLRP7
showed upregulation in D3 arrested embryos but downregulation in
D5 when compared with normal embryos at the same stages.
It is not easy to obtain human oocytes and embryos for research,
but in our large in vitro fertilisation programme, we have ethics
approvals to get immature oocytes, which cannot be used for
intracytoplasmic sperm injection, and mature them in vitro to
metaphase II. We can also get cryo- preserved human embryos
that the couples do not want to use for infertility treatment any
more. Clearly abnormal embryos are also available for research in
some occasions. Any functional experiments using these scarce
human oocytes and embryos are not feasible. We could, however,
using microarrays, real-time PCR, extensive bioinformatics
Figure 2. Microarray detection of NLRPs in human oocytes and
embryos showed two different expression patterns. A: NLRP4, 5,
8, 9, 11,12, 13 and14 were highly expressed in oocytes and then
gradually decreased in embryos with a very low level in day5 (D5)
embryos. B: NLRP2 and NLRP7 progressively decreased from oocytes to
day 3(D3) embryos then showed a sharp increase in D5. Error
bars=SEM (standard error of the mean).
doi:10.1371/journal.pone.0002755.g002
Figure 3. RT-PCR detection of NLRPs in human oocytes and
embryos showed two expression patterns. A: NLRP4, 5, 8, 9, 11,12,
13 and 14 were highly expressed in oocytes and then gradually
decreased in embryos with a very low level in day5 (D5) embryos. B:
NLRP2 and NLRP7 progressively decreased from oocytes to day 3(D3)
embryos, then showed a sharp increase in D5. Error bars=SEM
(standard error of the mean).
doi:10.1371/journal.pone.0002755.g003
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obtain a large amount of really new information regarding the
function of these genes in human early development.
NLRP5 and NLRP9
NLRP5 (Mater) is essential for mouse early embryonic
development beyond the two-cell stage [6]. In mice, transcripts
of NLRP5 are detected in oocytes from the primary follicle
onwards, but they are not detectable in any stages of preimplan-
tation embryos. NLRP5 protein is present until the late blastocyst
stage in mice [17]. In bovine, the transcripts of NLRP5 have the
same expression pattern as we found in humans [12]: NLRP5i s
expressed at a high level in oocytes, and remains detectable after
fertilization. It declines in preimplantation embryos and becomes
hardly detectable in blastocysts.
The expression of NLRP 9 has been thought to be restricted to
oocytes and the testis because it was not detected in somatic tissues
in bovine [11,18]. NLRP9 is also found exclusively expressed in
oocytes in mice [19]. According to public databases, NLRP9 is also
expressed in lung, placenta, thymus, intestine, brain and prostate.
We observed that NLRP9 declined gradually from oocytes to
blastocysts. Consistent with our study, similar expression patterns
are also reported by two other studies on bovine [11,18].
NLRP9 had a similar expression picture as NLRP5 in both
normal and abnormal embryos. The decrease of NLRP9 in D1
abnormal embryos implies its possible roles in the fertilization and
zygote development; while the increase of NLRP9 in D3, D5
arrested embryos suggests it is probably not needed in normal D3
and D5 embryos.
NLRP7 and NLRP14
Opposite to other NLRPs, the expression of NLRP7 did not
decrease in D5 embryos. It increased from D3 to D5, and was
downregulated in developmentally-arrested D5 embryos. All these
results suggest its potential role in later embryonic development in
humans. This hypothesis is supported by the association of NLRP7
mutation with abnormal embryo development in humans [8]. The
link between overexpression of NLRP7 and tumor development
suggests that NLRP7 participates in cell proliferation and/ or cell
differentiation. The involvement of NLRP7 in inflammation (where
NLRP7 is referred to as PYPAF3) implies possible participation of
NLRP7 in other pathways [20].
NLRP14 has been thought to be a testis-specific gene in humans
and it might participate in inflammation as well [10]. However,
mouse NLRP14 protein is found in oocytes at all stages of follicles,
except primordial follicles; whereas no signal is detected in testis in
the same study [21]. In our study, NLRP14 was detected in
oocytes, spermatozoa and embryos. It shared a similar expression
pattern with NLRP5 and NLRP9. The inconsistency in the results
for NLRP14 could be due to species variance, or due to the diverse
nominating of the same genes.
NLRP12
NLRP12 is also known as PYPAF7. The expressionof NLRP12 has
beenreported to be highly restricted to immune cells, there NLRP12
activates inflammatory signaling pathways [22,23]. So far, there is
no literature showing any relationship between NLRP12 and
reproduction. The expression levels of NLRP12 in oocytes,
spermatozoa and embryos were relatively low when compared to
that of NLRP5. The expression pattern of NLRP12 was similar to
that of NLRP5 and NLRP9, both in normal and abnormal embryos.
Similar to NLRP9, NLRP12 is most likely involved in the fertilization
and zygote development, but in D3, D5 development.
The indirect comparison between D1 abnormal embryos
and D2 normal embryos
Although the comparison between D1 abnormal embryos and
D2 normal embryos was not direct, we could still show that there
Figure 4. Expression of NLRP5, 9, 12, 7 in day 1 abnormal embryos, RT-PCR results. Unfert. Oocyte= Unfertilized oocytes at day 1; 1PN=
fertilized oocyte with 1 pronucleus at day 1; (3PN)= fertilized oocytes with 3 pronuclei at day 1. The expression levels of NLRP5, 9, 12 and 7 in day 1
abnormal embryos were lower than in normal ones. Error bars=SEM (standard error of the mean).
doi:10.1371/journal.pone.0002755.g004
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embryos. According to the overall expression patterns, D1
embryos should contain a higher level of NLRPs than D2 embryos.
Here we saw the opposite trend instead. It suggests that the
expression level of NLRP5, 7, and 9 in D1 abnormal embryos was
much lower than in normal D1 embryos. There was a
downregulation of these four NLRPs in D1 abnormal embryos.
We can also exclude the possibility that this downregulation is due
to degradation of mRNA in abnormal embryos by the observation
that NLRP 5, 9,12 hade very high expression levels in D3 and D5
abnormal embryos. If there was a degradation of mRNA in
abnormal embryos, the expression levels of these genes in
abnormal D3 and D5 embryos would have been much lower.
Overall, the information presented in our study provides clear
clues for better understanding of the roles of all NLRP family
members in human reproduction. The changed expression of
NLRPs in abnormal oocytes and embryos further suggests that they
have potential roles in preimplantation development in humans.
Materials and Methods
Collection of human oocytes and embryos
This study was approved by the Ethics Committees of
Karolinska Institute, Karolinska University Hospital Huddinge
and O ¨ rebro University Hospital. Informed consent was obtained
from all the oocyte, sperm and embryo donors. None of the donors
received any financial reimbursement. The researchers of this
study did not participate in obtaining consent.
Morphologically normal fully-grown germinal vesicle (GV) and
metaphase I (MI) oocytes were donated by healthy women
undergoing intracytoplasmic sperm injection (ICSI) treatment due
to male factor infertility as described elsewhere [13]. Such oocytes
Figure 5. Expression of NLRP5, 9, 12, 7 in day 3 (D3) and day5 (D5) abnormal embryos. D3 stop dev.= Embryos stop develop at D3; D5
stop dev.= Embryos stop develop at D5. A: the expression levels of NLRP5, 9, 12 and 7 in development arrested D3 embryos were higher than in
normal D3 embryos. B: the expression levels of NLRP5, 9 and 12 in development arrested D5 embryos were much higher than in normal D5 embryos,
but the expression level of NLRP 7 in development arrested D5 embryos was much lower than in normal ones. Error bars=SEM (standard error of the
mean).
doi:10.1371/journal.pone.0002755.g005
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obtained by in vitro maturation of such donated GV oocytes. The
basic culture medium for oocyte maturation was Tissue Culture
Medium199 (Sigma, St. Louis, MO, USA), supplemented with
10% patient‘s serum, 0.3 mM pyruvate (Sigma; St. Louis, MO),
0.075 IU/ml FSH and 0.5 IU/ml HCG (Serono, Rome, Italy).
Only embryos that could not be used in the infertility treatment
were used for this study. They were from either conventional in
vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
They had been cryopreserved at the 2–8-cell stage using a three-
step propanediol cryopreservation kit (Freeze kit 1; Vitrolife AB,
Gothenburg, Sweden). In this study, these embryos were then
thawed (Sydney IVF thawing kit, CooK IVF, Brisbane, Australia)
and used at the 4-cell (D2) or 8-cell (D3) stage, or further cultured
to the blastocyst stage (D5) in either BlastAssist System (Medicult,
Jyllinge, Denmark) or blastocyst sequential media (Sydney IVF
Blastocyst medium, CooK IVF, Brisbane, Australia).
Abnormal oocytes and embryos were collected from the clinic on
the day they were to be discarded. They included unfertilized oocytes
at day 1 (Unfert. oocyte), fertilized oocytes with 1 pronucleus at day 1
(1PN),fertilized oocyteswith3pronucleiatday1 (3PN),and embryos
that stopped developing (stop dev.) at D3 and D5.
Oocytes and embryos were stored in RNAlater at 270uC. Prior
to cDNA synthesis, they were thawed at room temperature in
RNAlater, then moved to RNase-free PBS and washed three times
before being frozen in 2 ml RNase-free H2O. Three to five oocytes
or embryos were pooled together as one sample. Re-thawed
oocytes and embryos were ready for cell-direct cDNA synthesis.
Collection of human spermatozoa
Semen samples were donated by healthy males who underwent
IVF treatment due to female infertility. Spermatozoa were obtained
after standard preparation from ejaculated semen samples. Swim-
up technique was used for spermatozoa preparation in all cases.
Figure 6. Phylogenetic analysis of the NLRP family. Homology of NLRP members between mouse and human was high, except for NLRP8.
Figure showed three clusters: (1) Nalp2 and NALP7; (2) NLRP 11, 4, 9, 5, 13, 14, 8; (3) NLRP1, 6, 10, 3. The clustering of the NLRP members fits well with
their expression patterns in human oocytes and embryos.
doi:10.1371/journal.pone.0002755.g006
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Crismas computer spermatozoa analyzer (Image House, Denmark).
Only samples with normal concentration and spermatozoa motility
between 95 and 100% in final suspension were used for this study.
Afterbeing washedthree timesinRNase-free PBS, the spermatozoa
were transferred to 350 ml of RNA lysis buffer (Qiagen, Hilden,
Germany) and stored at 270uC until RNA extraction.
Real-time PCR (RT-PCR)
Materials used for real-time were different from those used in
microarray. Experiments were repeated three times for each
sample type using different materials.
Oocyte and embryo cDNA was synthesized using Super-
Script
TM III CellsDirect cDNA Synthesis system (Invitrogen,
Stockholm, Sweden). Spermatozoa cDNA was synthesized with
SuperScript
TM III First-Strand Synthesis system for RT-PCR
(Invitrogen, Stockholm, Sweden) after RNA extraction using
RNeasy mini kit (Qiagen, Hilden, Germany). Oligo-dT was used
for reverse transcription for all the samples. The total volume of
reverse transcription is 21 ml. All the primers (Table 1) are
designed by Primer Press 3.0, software for optimal primer/probe
design provided by Applied Biosystems. All primer pairs span
intron-exon boundaries. SYBR Green technology was applied for
all the assays with ABI 7500 standard qPCR system (Applied
Biosystems, Foster City, CA). The total reaction volume was 10 ml,
including 5 ml 2X Power SYBR Green PCR master mix (Applied
Biosystems, Warrington, UK), 0.4 mlo f5mM forward primer,
0.4 mlo f5mM reverse primer, 1 ml cDNA template, and 3.2 ml
H2O. Negative controls without template were added each time.
Proteasome subunit, beta type 6, also named Proteasome subunit
Y( PSMB6), was used as an internal control. The PCR program
started with 50uC, 2 minutes; 95uC, 10 minutes; followed by 40
cycles of 95uC, 15 seconds; 60uC, 50 seconds; and ended with
95uC, 15 seconds; 60uC, 1 minute; 95uC, 15 seconds. The ending
step of PCR is performed to acquire the dissociation curve,
validating the specificity of the PCR products. Comparative
method was used for fold-change calculation. The PCR products
were taken to run agarose gel (2.5%; stained with 50 _g/mL
ethidium bromide). A 50 -base pair DNA ladder (Invitrogen) was
used as the size marker.
Phylogenetic analysis of the NLRP family
Multiple alignment of the sequences was performed with the
software ClustalX [24], while the trees where produced with
TreeView 1.6.6 [25]
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